Zygomatic And Pterygoid Implants Market Report Scope & Overview:

The Zygomatic And Pterygoid Implants Market was valued at USD 290.02 Million in 2025 and is expected to reach USD 560.12 Million by 2035, growing at a CAGR of 6.84% from 2026-2035.

The Zygomatic And Pterygoid Implants Market is becoming more robust due to the increasing number of patients with major maxillary bone atrophy as well as increasing need for graftless full-arch reconstruction procedures. The implants placed immediately in the maxillary bone that anchor to the zygomatic bone or pterygoid plates demonstrate good long-term outcomes, allowing the patient to have fixed teeth without having extensive bone grafts performed. Digital dentistry technologies such as cone-beam CT planning, guided surgery, and dynamic navigation technologies are helping to decrease the learning curve for surgeons. Simultaneously, the development of dental tourism and new training centers contributes to increased patient access to these treatments.

⮞In February 2026, Noris Medical published a clinical case demonstrating dynamic CBCT navigation for placing zygomatic and pterygoid implants in full-arch rehabilitation. The workflow addresses accuracy and surgical risk concerns that limit wider adoption, supporting faster surgeon training for complex implant trajectories.

U.S. Zygomatic And Pterygoid Implants Market Outlook

The U.S. Zygomatic And Pterygoid Implants Market was valued at USD 101.36 Million in 2025 and is expected to reach USD 190.56 Million by 2035, growing at a CAGR of 6.52% from 2026-2035.

The U.S. Zygomatic And Pterygoid Implants Market is expanding owing to a large aging population with complete tooth loss, high demand for fixed full-arch restorations, and strong adoption of digital implant workflows. Zygomatic and pterygoid implants are regulated as Class II devices and generally reach the market through the FDA’s 510(k) pathway, with several recent clearances widening product choice. Leading companies such as Straumann, Nobel Biocare, Dentsply Sirona, and ZimVie operate extensive surgeon training networks. Private insurers often cover oncology and trauma-related reconstruction, while self-paying patients drive most elective full-arch cases. Outpatient oral surgery centers are also steadily expanding their full-arch treatment capacity nationwide.

⮞In August 2025, Nobel Biocare received FDA 510(k) clearance for NobelZygoma TiUltra, including labeling for quad-zygomatic indications and implant lengths up to 60 mm. The clearance confirmed that predicate-based evidence can support approval of extra-maxillary devices, strengthening Nobel Biocare’s position among U.S. oral surgeons treating severe maxillary atrophy.

By Product Type, Zygomatic Implants Lead, While Pterygoid Implants Grow Fastest

Zygomatic implants segment dominated the Zygomatic And Pterygoid Implants Market in 2025, as these long implants anchor in the dense cheekbone and support most graft-free full-arch restorations in patients with severe upper jaw bone loss. Established systems such as NobelZygoma, Straumann’s ZAGA, and Southern Implants’ zygomatic range have extensive clinical data showing survival rates above 97% over many years. Surgeons can place two or four zygomatic implants to support fixed teeth within a day. Strong training programs and broad product portfolios from leading manufacturers continue to support this segment’s leading share. Longer implant options and quad protocols further broaden treatment eligibility for many patients.

Pterygoid implants are the fastest-growing product type, as surgeons increasingly combine them with anterior zygomatic or conventional implants to support the back of the upper jaw without sinus lifts. Anchoring in the pterygoid plates provides stable posterior support and reduces long cantilevers in full-arch prostheses, improving load distribution. Clinical studies report six-year success rates above 95%, building surgeon confidence. New FDA clearances for pterygoid indications and growing educational content, including guidance on pterygoid implant planning, are encouraging wider adoption beyond specialized zygomatic centers throughout the forecast period. Pterygoid implants also avoid the sinus, lowering complication risk for many patients undergoing full-arch treatment.

⮞In June 2026, BioHorizons launched its Pro Zygoma implant system for advanced full-arch rehabilitation in patients with severely resorbed maxillae, expanding its portfolio with a dedicated remote-anchorage solution and additional prosthetic options for complex implant-supported restorations.

By Procedure Approach, Immediate Loading Leads and Grows Fastest

Immediate loading segment dominated the Zygomatic And Pterygoid Implants Market in 2025 and is also the fastest-growing approach, as patients increasingly expect fixed teeth on the day of surgery. Zygomatic and pterygoid implants achieve high primary stability through anchorage in dense bone, making same-day provisional bridges predictable. Pooled clinical analyses report survival rates of around 98% for immediately loaded zygomatic implants. Avoiding bone grafts shortens total treatment time from many months to a few days, improving patient satisfaction and clinic productivity while reducing the number of surgical procedures required overall. Surgeon confidence in immediate-function protocols continues to rise steadily across major markets.

Delayed loading still plays a significant role in the treatment of patients with low implant stability, weak bone density, heavy smoking, or other illnesses that increase the healing risk. In such cases, doctors postpone the fixation of the final prosthesis until the full integration of the implant into the bone occurs. However, the percentage of delayed loading will decrease due to advances in digital planning, development of implant surfaces, and use of multi-unit abutments for same day teeth. Moreover, manufacturers promote their newest products for immediate function, which further supports the transition to immediate loading.

⮞In July 2025, Clinical Oral Implants Research published a practice-based study examining patient-reported outcomes after immediate-loaded, zygomatic implant-supported fixed rehabilitation in patients with edentulous, atrophic maxillae, adding clinical evidence on patient experience with immediate-function treatment protocols.

By End User, Hospitals Lead, While Ambulatory Surgical Centers Grow Fastest

Hospitals segment dominated the Zygomatic And Pterygoid Implants Market in 2025, since most zygomatic surgeries necessitate the use of general anesthesia and patients with complicated medical histories. Hospitals have all the necessary amenities such as operating rooms, anesthesia units, and multidisciplinary support required for the reconstruction of cancer-related maxillectomy, trauma, and quad-zygomatic procedures. Academic hospitals serve as educational institutions for oral and maxillofacial surgeons who learn how to conduct extramaxillary surgery. The link between oncology and trauma cases and hospitals because of the insurance coverage associated with them is another factor contributing to the dominant market share of the sector throughout the forecast period. Hospitals help to manage patients safely with complicated conditions like diabetes and heart diseases.

Ambulatory surgical centers are expected to grow at the fastest rate among the end-users owing to the move towards outpatient surgery for elective full arch procedures which decrease costs and allow same-day discharge. This segment combines surgical facilities, sedation and digital imaging. In the U.S., increased payment for complex dental rehabilitation drives the development of oral surgery center business in the outpatient setting. Dental clinics having modern CBCT imaging and office-based anesthesia facilities increase their involvement in these procedures step-by-step and thereby gradually increase the number of regions worldwide where zygomatic surgeries take place. Private equity-financed oral surgery groups are growing rapidly in the U.S.

⮞In August 2025, Great Hill Partners acquired a majority interest in Blue Cloud Pediatric Surgery Centers, expanding investment in a U.S. network specializing in outpatient dental and oral surgery for pediatric and special-needs patients and highlighting continued commercial investment in specialized ambulatory surgical infrastructure.

Regional Analysis

North America Zygomatic And Pterygoid Implants Market Insights

North America accounted for approximately 40.72% of the Zygomatic And Pterygoid Implants Market in 2025, the largest share among all regions, supported by high disposable incomes, a large aging edentulous population, and strong adoption of full-arch implant dentistry. The United States generates most regional revenue, with leading manufacturers including Nobel Biocare, Straumann, Dentsply Sirona, ZimVie, and BioHorizons. Recent FDA 510(k) clearances for zygomatic and pterygoid systems from companies such as S.I.N. Implant System and JDentalCare have widened product choice. Dense continuing-education networks also help surgeons learn complex procedures. Growing patient awareness of graft-free options further supports regional procedure volumes across both countries.

Canada contributes a stable share, supported by provincial programs that subsidize medically necessary reconstructions after cancer surgery or trauma. Mexico is an important regional market, attracting large numbers of U.S. patients seeking lower-cost full-arch implant procedures in border cities and resort areas. Growing ownership of CBCT scanners and digital planning software among oral surgeons is increasing the number of practices able to offer zygomatic treatment. However, high treatment costs of USD 15,000 to USD 40,000 per arch and limited insurance coverage for elective cases continue to restrict wider adoption across the region. Patient financing plans are partly easing this barrier for many elective cases.

⮞In December 2025, the Journal of Oral Implantology published a retrospective analysis of 262 zygomatic implants used to treat severe maxillary atrophy, examining long-term survival, complications, and patient satisfaction across quad-zygomatic and hybrid approaches, adding clinical evidence relevant to complex implant rehabilitation.

Europe Zygomatic And Pterygoid Implants Market Insights

Europe continues to be the second-largest regional market, supported by Germany, France, the UK, Italy, and Spain, where aging populations and strong implant dentistry traditions drive demand. The zygomatic implant concept was first developed in Europe, and the region remains a center of clinical research and surgeon training. Leading companies such as Straumann, Nobel Biocare, Neoss, and Southern Implants have strong European operations. The EU Medical Device Regulation governs these implants, raising clinical evidence requirements while allowing harmonized market access across member states for companies with strong documentation. Strong academic research networks and surgeon training centers further support clinical adoption.

Core demand is driven by Germany, France, and the UK due to large implant markets and developed networks of oral surgeons. Spain and Hungary have become significant centers for dental tourism because of full-arch treatment at prices 30-50% lower than in Western Europe. The contribution of Italy is ensured by large numbers of implantologists and clinical researches. The increasing use of immediate-loading techniques facilitates growth of the region. However, the burden of MDR paperwork and the financial pressure on elective dental care may affect negatively the growth of small regional manufacturers. In turn, large companies with clinical evidence are in good positions.

⮞In February 2026, Clinical Oral Implants Research published an international consensus report developed using the German AWMF clinical-guideline framework, establishing six recommendations for selecting and planning implant-supported rehabilitation in edentulous patients, including those with severe maxillary atrophy who may require zygomatic implants.

Asia-Pacific Zygomatic And Pterygoid Implants Market Insights

Asia-Pacific is currently witnessing the highest growth rate in the Zygomatic And Pterygoid Implants Market, anticipated to record a CAGR of around 9.18% during the forecast period from 2026 to 2035, due to large aging populations, rising incomes, and rapid growth of implant dentistry. China is the largest market in the region, driven by expanding private dental hospital chains, growing demand for full-arch restorations, and volume-based procurement programs that have lowered implant prices. Increasing numbers of Chinese oral surgeons are completing zygomatic training, supporting wider adoption in major cities. Rising patient awareness of same-day fixed teeth is further increasing demand.

India remains one of the key markets in terms of growth, driven by a growing number of edentulous people, high levels of dental tourism, and increasing numbers of implant surgeons. Japan and South Korea are highly valued as locations due to the quality of their dental care system and aging population. Manufacturers from South Korea such as Osstem Implant, MegaGen, and Dentium keep expanding their operations in the region. Thailand and Singapore provide dental tourism services which include imaging, surgery and prosthetics placement. Australia has a constant flow of patients due to its good oral surgery system and early adoption of digital processes.

⮞In September 2026, China's National Healthcare Security Administration announced preparations for the next round of centralized procurement of dental implant systems, expanding participation by specialist dental institutions and reviewing procurement rules to improve affordability and implementation, with potential implications for implant access and purchasing across China's dental-care market.

MEA & Latin America Zygomatic And Pterygoid Implants Market Insights

The Middle East & Africa region represents a smaller but growing share of the Zygomatic And Pterygoid Implants Market, led by Gulf Cooperation Council states such as the UAE and Saudi Arabia, where affluent populations increasingly seek advanced full-arch implant solutions. Government-funded specialty centers are recruiting European-trained surgeons to run digital implant suites and offer complex rehabilitation. Growing medical tourism in Dubai is also attracting regional patients. Israel contributes as a manufacturing base for companies such as Noris Medical and Adin. South Africa anchors demand in Africa, supported by Southern Implants, a leading zygomatic implant developer with strong global reach.

Latin America is experiencing steady growth, with Brazil leading the region owing to its large private dental sector, strong implant manufacturing base, and high number of trained implant surgeons. Brazilian companies such as S.I.N. Implant System are expanding internationally, including recent FDA clearances for zygomatic systems. Argentina attracts patients from neighboring countries with cost-competitive clinics offering full-arch procedures. Colombia and Costa Rica are growing dental tourism destinations for North American patients. However, currency volatility, limited insurance coverage, and a shortage of specialized surgeons outside major cities continue to restrain faster regional growth. Expanding training programs are gradually improving patient access across the region.

⮞In November 2025, Saudi Arabia's Ministry of Health published Version 2.0 of its Clinical Guideline for Dental Implant Practice, providing updated professional guidance for implant treatment and supporting more standardized clinical decision-making within the country's developing dental-care sector

Market Dynamics

Growth Drivers: Rising Maxillary Atrophy and Graft-Free Rehabilitation

Increased Demand for Zygomatic and Pterygoid Implants is fueled by the rising prevalence of severe cases of maxillary bone resorption and total tooth loss in mature patients. According to the World Health Organization, the majority of adults around the globe have been suffering from severe periodontal disease, which leads to substantial bone resorption after tooth loss occurs. These people cannot get conventional implants due to the need for bone grafting procedures. In terms of the increase in the number of older people to 1.5 billion by 2050, the demand for advanced implant solutions will continue to grow on the market.

The advantages of graft-less and immediate loading rehabilitation contribute to the growth of the market. The zygomatic and pterygoid implants help patients to get their fixed teeth within a day without the need for bone grafting, which is usually associated with 6-12 months of healing period. The pooled results indicate the survival rate of around 98% in case of immediately loaded zygomatic implants, and the quad-zygomatic approach yields similar outcomes. Avoiding graft procedures saves time and money and decreases patient discomfort. The digital planning, guided surgery and dynamic navigation help to improve the accuracy and increase the number of surgeons who can provide these procedures.

⮞In December 2025, the Journal of Oral Implantology published five-and-a-half-year retrospective findings from patients treated with quad-zygomatic and hybrid implant approaches for severe maxillary atrophy, providing additional clinical evidence on implant survival, complications, and patient satisfaction in graft-free rehabilitation.

Restraints: High Costs and Steep Surgical Learning Curve

High procedure and implant costs remain a key factor limiting market growth. In North America, one arch of zygomatic rehabilitation typically costs between USD 15,000 and USD 40,000, well above the cost of conventional implant treatment. Most dental insurance plans cover only a small part of implant costs, and medical insurers generally limit coverage to cancer, trauma, or congenital defect cases. As a result, many patients must pay out of pocket or seek treatment abroad. Cross-border treatment can complicate follow-up care, warranty support, and the management of complications after surgery. Financing options may help ease some of these cost barriers.

The steep surgical learning curve is another limiting factor, as zygomatic implant placement involves complex trajectories near critical structures such as the eye socket and maxillary sinus. Surgeons require extensive training, including cadaver courses and supervised live surgeries, before performing these procedures independently. Studies show higher sinusitis and complication rates among surgeons with limited case experience. The global pool of trained specialists remains small, particularly in emerging markets. Post-operative sinus complications and regulatory uncertainty for extra-maxillary devices in some countries can further slow adoption among general implant dentists. Structured manufacturer-led training academies are gradually helping address these important skill gaps.

Opportunities: Digital Workflows and Emerging Market Expansion

The development of integrated digital workflows creates a significant opportunity for manufacturers, as planning accuracy and complication management are becoming key purchasing criteria. Solutions that combine CBCT-based planning, guided surgery, dynamic navigation, and dedicated implant-prosthetic kits can lower the learning curve and expand the number of surgeons able to perform these procedures. AI-based planning tools that work across implant brands may further simplify case preparation. Companies that invest in training academies, strong clinical evidence, and post-market follow-up systems can build lasting relationships with surgeons and strengthen their competitive position. Remote case planning and support services can also improve surgical outcomes.

At the same time, rapid growth of implant dentistry in Asia-Pacific, Latin America, and the Middle East provides a major growth opportunity. Rising incomes, aging populations, and expanding private dental chains are increasing demand for full-arch rehabilitation in China, India, Brazil, and the Gulf states. Dental tourism destinations such as Turkey, Hungary, Mexico, Thailand, and Costa Rica continue to attract patients seeking affordable complex treatments. Lower-priced implant systems from manufacturers in South Korea, Israel, and Brazil can widen access in price-sensitive markets. Local training programs will be essential to support sustainable adoption. Local distribution partnerships can also speed market entry for new suppliers.

⮞In September 2026, researchers affiliated with Sun Yat-sen University in China published a clinical study evaluating dynamic navigation combined with guide plates for zygomatic implant placement, reporting improved placement accuracy compared with guide plates or freehand surgery alone and highlighting opportunities to refine digitally assisted workflows for complex implant procedures.

Zygomatic And Pterygoid Implants Market Key Players

• Straumann Holding AG

• Nobel Biocare Services AG (Envista Holdings)

• Noris Medical Ltd.

• S.I.N. Implant System

• Southern Implants (Pty) Ltd.

• Adin Dental Implant Systems Ltd.

• Bioline Dental Implants

• TitaniumFix

Zygomatic And Pterygoid Implants Market Report Scope: